Literature DB >> 8791694

Cells and cytokines in resistance to Toxoplasma gondii.

C A Hunter1, Y Suzuki, C S Subauste, J S Remington.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8791694     DOI： 10.1007/978-3-642-51014-4_11

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  16 in total

1.  Disruption of the Toxoplasma gondii bradyzoite-specific gene BAG1 decreases in vivo cyst formation.

Authors:  Y W Zhang; K Kim; Y F Ma; M Wittner; H B Tanowitz; L M Weiss
Journal:  Mol Microbiol       Date:  1999-01       Impact factor: 3.501

2.  Genetic approaches to studying virulence and pathogenesis in Toxoplasma gondii.

Authors:  L David Sibley; Dana G Mordue; Chunlei Su; Paul M Robben; Dan K Howe
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-01-29       Impact factor: 6.237

3.  In vivo effect of anti-TNF agent (etanercept) in reactivation of latent toxoplasmosis.

Authors:  Nagwa Mostafa El-Sayed; Khadiga Ahmed Ismail; Abeer Fathy Badawy; Khaled Fathy Elhasanein
Journal:  J Parasit Dis       Date:  2015-09-24

4.  Granule-dependent killing of Toxoplasma gondii by CD8+ T cells.

Authors:  Y Nakano; H Hisaeda; T Sakai; M Zhang; Y Maekawa; T Zhang; M Nishitani; H Ishikawa; K Himeno
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

5.  Targeted disruption of the GRA2 locus in Toxoplasma gondii decreases acute virulence in mice.

Authors:  C Mercier; D K Howe; D Mordue; M Lingnau; L D Sibley
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

6.  Role of NK cells and gamma interferon in transplacental passage of Toxoplasma gondii in a mouse model of primary infection.

Authors:  Ahmed Abou-Bacar; Alexander W Pfaff; Sophie Georges; Valérie Letscher-Bru; Denis Filisetti; Odile Villard; Elisabeth Antoni; Jean-Paul Klein; Ermanno Candolfi
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

7.  Vaccination with Toxoplasma gondii SAG-1 protein is protective against congenital toxoplasmosis in BALB/c mice but not in CBA/J mice.

Authors:  Valerie Letscher-Bru; Alexander W Pfaff; Ahmed Abou-Bacar; Denis Filisetti; Elisabeth Antoni; Odile Villard; Jean-Paul Klein; Ermanno Candolfi
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

8.  The p29 and p35 immunodominant antigens of Neospora caninum tachyzoites are homologous to the family of surface antigens of Toxoplasma gondii.

Authors:  D K Howe; A C Crawford; D Lindsay; L D Sibley
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

9.  Different strains of Toxoplasma gondii induce different cytokine responses in CBA/Ca mice.

Authors:  Fausto G Araujo; Teri Slifer
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

10.  Effect of trovafloxacin on production of cytokines by human monocytes.

Authors:  A A Khan; T R Slifer; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.